Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on May 4, 2026

May 4, 2026

Sitestream, A Polaris Group Company, now an 'Awarded Vendor' by the North Carolina Sheriffs' Association

Indeterminate EIN Presswire

May 4, 2026

Actually Health Announces Virtual Care Membership That Gets Smarter With Every Patient

Indeterminate EIN Presswire

May 4, 2026

Lionbridge Names Sebastian Bretschneider Chief Executive Officer

Indeterminate EIN Presswire

May 4, 2026

Creatio Sets a New Standard for Enterprise Software Pricing in the Age of AI

Indeterminate EIN Presswire

May 4, 2026

Lydonia Showcases Proven Invoice Processing Solution Delivering Measurable Finance Results

Indeterminate EIN Presswire

May 4, 2026

C10 Labs and Pegasystems launch Applied AI Accelerator in Cambridge for Summer 2026

Indeterminate EIN Presswire

May 4, 2026

Axiant Launches with Innovative Process-First Methodology to Address Automation Failures

Indeterminate GlobeNewswire

May 4, 2026

Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study

Indeterminate GlobeNewswire

May 4, 2026

NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU

Indeterminate GlobeNewswire

May 4, 2026

Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities

Indeterminate GlobeNewswire

May 4, 2026

JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering

Indeterminate GlobeNewswire

May 4, 2026

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

Indeterminate GlobeNewswire

May 4, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

Teva to Present at the BofA Securities Health Care Conference

Indeterminate GlobeNewswire

May 4, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

Cellectis to Report First Quarter Financial Results on May 11, 2026

Indeterminate GlobeNewswire

May 4, 2026

Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026

Indeterminate GlobeNewswire

May 4, 2026

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Microvast Schedules First Quarter Earnings Call

Indeterminate GlobeNewswire

May 4, 2026

Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program

Indeterminate GlobeNewswire